News

Découvrir plus d'actualités

  • 04.12.2023

    UBP London’s ambitious Nature Calls conference draws a crowd

    We recently held our first biodiversity conference in London, titled ‘Nature Calls!’ featuring a varied batch of panellists who led inspiring keynote speeches and discussions.

  • 29.11.2023

    Fixed income 2024: investment grade offers attractive risk-return

    Yields on investment-grade bonds are at levels not seen since the GFC, propelled by an inflation wave that caught central banks off guard, forcing them to make the fastest set of rate-hikes since the 1980s.

  • 28.11.2023

    Bell’s small & mid-cap portfolio – a bellwether

    Today, global SMID caps might represent one of the last areas within equities where the balance between fundamentals and valuations has been largely preserved.

  • 21.11.2023

    European real estate: capitalising on market dislocations

    The real estate market has had its share of upheavals and is in flux as Europe’s economies battle with the consequences of rising inflation and interest rates, weakening demand, and contracting exports, not to mention the unrest in Eastern Europe and the Middle East. Meanwhile real estate has its place as a value creator in investors’ portfolios.

  • 08.11.2023

    Global equities: time in the market rather than timing the market

    With a rebound in EPS growth expected for 2024, though with disparities between market segments, and with interest rates and inflation still at elevated levels, active management is key.

  • 07.11.2023

    Investissement d’impact ou la difficile gestion des attentes court terme

    Le Temps (06.11.2023) - Ces deux dernières années, les stratégies d’impact ont connu une évolution plutôt décevante comparé notamment à celles centrées sur les valeurs phares de la technologie.

  • 30.10.2023

    Actions globales: les clés d’une diversification efficiente

    La recherche a démontré qu’il était suffisant de détenir 30 actions en portefeuille pour bénéficier d’une diversification efficiente du risque, et ce sans même tenir compte des avantages additionnels liés à une sélection de titres active.

  • 13.10.2023

    Assessing positive impact in pharmaceuticals

    Pharma is a complex and fast-changing industry that plays a vital role in improving health outcomes and global access to medicines.

  • 15.09.2023

    Investir dans la prochaine génération d’infrastructures

    Le Temps - (28.08.2023) - S’ils connaissent aujourd’hui une période plus difficile, les marchés privés ont, sur les vingt dernières années, mieux performé que les indices des marchés publics correspondants.

Our latest podcasts

Our latest podcasts

Inscrivez-vous à nos newsletters